BEYOND AIR INC. - COMMON STOCK

Beyond Air® Schedules Fiscal Year 2021 Financial Results Conference Call and Webcast

25 May 2021 07:30:00 By Nasdaq GlobeNewswire

Beyond Air® Strengthens Commercial Leadership Team with Appointments of Head of Sales and Head of Marketing

20 May 2021 08:00:02 By Nasdaq GlobeNewswire

Beyond Air® Presents Data in Hospitalized Patients with Viral Lung Infections (including COVID-19) from LungFit® PRO Programs at ATS 2021

13 May 2021 08:00:01 By Nasdaq GlobeNewswire

Beyond Air® Appoints Peter Senior as Director of Business Development

03 May 2021 08:00:01 By Nasdaq GlobeNewswire

Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in May 2021

14 Apr 2021 08:00:01 By Nasdaq GlobeNewswire

Beyond Air® to Present Abstracts at the American Thoracic Society Virtual Sessions in May 2021

24 Mar 2021 08:00:01 By Nasdaq GlobeNewswire

Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in March 2021

01 Mar 2021 08:00:01 By Nasdaq GlobeNewswire

Beyond Air® Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease

16 Feb 2021 08:00:11 By Nasdaq GlobeNewswire

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business Update

09 Feb 2021 16:05:00 By Nasdaq GlobeNewswire

Beyond Air® Schedules Third Fiscal Quarter 2021 Financial Results Conference Call and Webcast

15 Jan 2021 16:10:00 By Nasdaq GlobeNewswire